HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast

Revisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy

(2011) Amit K. Tiwari et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Characterization of rhodamine-123, calcein and 5(6)-carboxy-2′,7′-dichlorofluorescein (CDCF) export via MRP2 (ABCC2) in MES-SA and A549 cells

(2011) Vesna Munić et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Gastric Micropapillary Carcinoma

(2010) Dae-Woon Eom et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

YC-1, a novel potential anticancer agent, inhibit multidrug-resistant protein via cGMP-dependent pathway

(2010) Chin-Chuan Hung et al.   INVESTIGATIONAL NEW DRUGS

Incidence of pathologic complete response in women treated with preoperative chemotherapy for locally advanced breast cancer: correlation of histology, hormone receptor status, Her2/Neu, and gross pathologic findings

(2009) Isabel Alvarado-Cabrero et al.   Annals of Diagnostic Pathology

Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1α and P-glycoprotein overexpression

(2009) C Riganti et al.   BRITISH JOURNAL OF PHARMACOLOGY

Structural and biological properties of a papillary component generating a micropapillary component in lung adenocarcinoma

(2009) Tatsuya Nagano et al.   LUNG CANCER

Preoperative Systemic Chemotherapy and Pathologic Assessment of Response

(2009) Lajos Pusztai   PATHOLOGY & ONCOLOGY RESEARCH

Recent advances in three-dimensional multicellular spheroid culture for biomedical research

(2008) Ruei-Zhen Lin et al.   Biotechnology Journal

Asbestos induces doxorubicin resistance in MM98 mesothelioma cells via HIF-1 

(2008) C. Riganti et al.   EUROPEAN RESPIRATORY JOURNAL

Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast

(2008) C Marchiò et al.   JOURNAL OF PATHOLOGY

Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity

(2008) R. Sullivan et al.   MOLECULAR CANCER THERAPEUTICS